Brain Hippocampal atrophy & assimetry

QUIBIM

QUIBIM has developed an automatic tool analysis method to quantify the volume of both left and right hippocampus and compare them to a set of healthy patients to help in the early diagnosis and in the progression of patients with HA.
Product specifications Information source: Vendor
Last updated: March 10, 2020
General
Product name Brain Hippocampal atrophy & assimetry
Company QUIBIM
Subspeciality Neuro
Modality MR
Disease targeted Hippocampal atrophy, Brain atrophy, Temporal lobe epilepsy
Key-features Main region volume and total volume
Suggested use Without interference of a radiologist: AI-only diagnosis
Data characteristics
Population Patients associated with Temporal lobe epilepsy (TLE)
Input MRI T1 GRE 3D T1 Fast Gradient Echo
Input format
Output One-page structured report: 3D hippocampus render, hippocampus segmentation, table with volume statistics, normative graphs of volume and asymmetry
Output format DICOM Secondary Capture / PDF
Technology
Integration Integration in standard reading environment (PACS), Integration via AI marketplace or distribution platform, Stand-alone third party application, Stand-alone webbased
Deployment Locally on dedicated hardware, Locally virtualized (virtual machine, docker), Cloud-based, Hybrid solution
Trigger for analysis Automatically, right after the image acquisition
Processing time > 10 minutes
Certification
CE Certified, Class IIa
FDA No or not yet
Market presence
On market since 01-2019
Distribution channels
Countries present (clinical, non-research use) 6
Paying clinical customers (institutes) 5+
Research/test users (institutes)
Pricing
Pricing model License
Based on Number of installations, Number of analyses
Evidence
Peer reviewed papers on performance
Non-peer reviewed papers on performance
Other relevant papers